FindTrial
Sign In

Rituximab (active comparator)

DRUG2 trials

Sponsors

Charite University, Berlin, Germany, Cellectar Biosciences, Inc.

Conditions

Rheumatoid ArthritisWaldenstrom MacroglobulinaemiaWaldenstrom MacroglobulinemiaWaldenstrom Macroglobulinemia With Nodal DiseaseWaldenstrom's Macroglobulinaemia RefractoryWaldenstrom's Macroglobulinemia Recurrent

Phase 1

Comparison of B-cell Depletion by Rituximab and Anti-CD 19 CAR-T Therapy in Patients With Rheumatoid Arthritis
Active, not recruitingNCT06475495
Charite University, Berlin, GermanyRheumatoid Arthritis
Start: 2024-12-04End: 2027-06-01Target: 13Updated: 2026-03-05

Phase 3

Evaluation of Iopofosine I 131 vs. R-CD in WM Patients
Not yet recruitingNCT07766421
Cellectar Biosciences, Inc.Waldenstrom Macroglobulinaemia, Waldenstrom Macroglobulinemia, Waldenstrom Macroglobulinemia With Nodal Disease +2
Start: 2026-12-01End: 2035-01-01Target: 219Updated: 2026-08-14